The Heart Research Institute, 7 Eliza St, Newtown, NSW 2042, Australia.
Biochem J. 2013 Jan 15;449(2):531-42. doi: 10.1042/BJ20121210.
Oxidative modification of HDLs (high-density lipoproteins) by MPO (myeloperoxidase) compromises its anti-atherogenic properties, which may contribute to the development of atherosclerosis. Although it has been established that HOCl (hypochlorous acid) produced by MPO targets apoA-I (apolipoprotein A-I), the major apolipoprotein of HDLs, the role of the other major oxidant generated by MPO, HOSCN (hypothiocyanous acid), in the generation of dysfunctional HDLs has not been examined. In the present study, we characterize the structural and functional modifications of lipid-free apoA-I and rHDL (reconstituted discoidal HDL) containing apoA-I complexed with phospholipid, induced by HOSCN and its decomposition product, OCN- (cyanate). Treatment of apoA-I with HOSCN resulted in the oxidation of tryptophan residues, whereas OCN- induced carbamylation of lysine residues to yield homocitrulline. Tryptophan residues were more readily oxidized on apoA-I contained in rHDLs. Exposure of lipid-free apoA-I to HOSCN and OCN- significantly reduced the extent of cholesterol efflux from cholesterol-loaded macrophages when compared with unmodified apoA-I. In contrast, HOSCN did not affect the anti-inflammatory properties of rHDL. The ability of HOSCN to impair apoA-I-mediated cholesterol efflux may contribute to the development of atherosclerosis, particularly in smokers who have high plasma levels of SCN- (thiocyanate).
MPO(髓过氧化物酶)氧化修饰 HDL(高密度脂蛋白)会损害其抗动脉粥样硬化特性,这可能导致动脉粥样硬化的发生。虽然已经确定 MPO 产生的 HOCl(次氯酸)是针对 HDL 中的主要载脂蛋白 apoA-I(载脂蛋白 A-I)的,但 MPO 产生的另一种主要氧化剂 HOSCN(次硫氰酸)在产生功能失调的 HDL 中的作用尚未得到检验。在本研究中,我们描述了游离 apoA-I 和含有与磷脂结合的 apoA-I 的 rHDL(重构盘状 HDL)的结构和功能修饰,这些修饰是由 HOSCN 及其分解产物 OCN-(异氰酸根)引起的。HOSCN 处理 apoA-I 导致色氨酸残基氧化,而 OCN- 诱导赖氨酸残基的氨甲酰化生成同型瓜氨酸。rHDL 中所含的 apoA-I 更容易氧化色氨酸残基。与未修饰的 apoA-I 相比,将游离 apoA-I 暴露于 HOSCN 和 OCN- 会显著降低载有胆固醇的巨噬细胞中胆固醇流出的程度。相比之下,HOSCN 不影响 rHDL 的抗炎特性。HOSCN 损害 apoA-I 介导的胆固醇流出的能力可能导致动脉粥样硬化的发展,特别是在血浆 SCN-(硫氰酸盐)水平较高的吸烟者中。